Representing the developed world, the United States will maintain a 7.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$60.3 Million to the region's size and clout in the next 5 to 6 years. Over US$52.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Nucleic Acid Test (NAT) will reach a market size of US$78.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.7% over the next couple of years and add approximately US$504.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include:
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson & Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Grifols International SA
- Ortho Clinical Diagnostics, Inc.
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Blood Screening Market to Witness Moderate Growth
The Nucleic Acid Test (NAT) Segment to Register Highest Growth
Global Competitor Market Shares
Blood Screening Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increase in Blood Donation Rates to Bode Well for Market Growth
Percentage of People Preferring to Donate Blood by Select Countries: 2018
Various Initiatives to Donate Blood Propel Market Growth
Rising Incidence of Infectious Diseases
Total Number of Disease Cases Reported in the US due to Infected Fleas, Ticks, and Mosquitoes: 2004-2016
Disease Response Towards Climate Change during the Recent Past
Opportunities and Challenges in Blood Screening
Innovations to Propel Market Growth
Various Measures for Ensuring Donated Blood Safety, a Key Driver for Market Growth
Introduction of Novel Products to Support Market Growth
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
Market Facts & Figures
US Blood Screening Market Share (in %) by Company: 2019 & 2025
Market Facts & Figures
European Blood Screening Market: Competitor Market Share Scenario (in %) for 2019 & 2025
REST OF EUROPE
REST OF ASIA-PACIFIC
REST OF LATIN AMERICA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
F. HOFFMANN-LA ROCHE AG
GRIFOLS INTERNATIONAL SA
ORTHO CLINICAL DIAGNOSTICS
THERMO FISHER SCIENTIFIC
V. CURATED RESEARCH